Clinical data | N | % |
---|---|---|
Oral ulcers | 40 | 100.00 |
Genital ulcers | 32 | 80.00 |
Ocular manifestations | 31 | 77.50 |
a) Anterior segment involvement | 22 | 55.00 |
b) Posterior segment involvement | 9 | 22.5% |
Vascular venous involvement (DVT) | 18 | 45.00 |
Pathergy test (positive) | 11 | 27.50 |
Neurological manifestations | 10 | 25.00 |
a) Transient ischemic attacks | 7 | 17.50 |
b) Hemiplegia (UMNL) | 3 | 7.50 |
Skin lesions | 4 | 10.00 |
a) Pseudofolliculitis | 3 | 7.50 |
b) Erythema nodosum | 1 | 2.50 |
Vascular arterial involvement (pulmonary) | 3 | 7.50 |
A) Pulmonary thrombosis | 2 | 5 |
B) Pulmonary aneurysma | 1 | 2.5 |
BDCAF score | Range | Mean ± SD |
4–12 | 7.7 ± 2.6 |